Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | He earned his M.D. from the Medical School of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D., Ph.D.). |
| 2020-04-24 | He earned his M.D. from the Medical School of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D., Ph.D.). |
| 2021-04-21 | He earned his M.D. from the Medical School of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D., Ph.D.). |
| 2022-04-20 | He earned his M.D. from the Medical School of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D., Ph.D.). |
| 2023-04-19 | Dr. Platzer makes valuable contributions to the Board based on over twenty-five years’ experience in the biotechnology industry as a physician in hematology and medical oncology, as a corporate executive, and as a corporate director. |
| 2024-05-15 | He earned his M.D. from the Medical School of the University of Erlangen, where he also received his “Dr. med. habil.” (M.D., Ph.D.). |
| 2024-07-17 | The table below sets forth information known to us regarding the beneficial ownership of our Shares as of July 11, 2024 for: each of our directors; ... Dr. Erich Platzer: 64,161 shares. |
| 2024-12-30 | Name of Beneficial Owner: Dr. Erich Platzer |
Data sourced from SEC filings. Last updated: 2025-10-11